BeyondSpring Inc. (NASDAQ:BYSI - Get Free Report) rose 30% on Monday . The stock traded as high as $2.21 and last traded at $2.21. Approximately 204,049 shares were traded during trading, an increase of 672% from the average daily volume of 26,423 shares. The stock had previously closed at $1.70.
BeyondSpring Trading Up 13.6%
The firm's 50 day moving average price is $1.56 and its two-hundred day moving average price is $1.64.
BeyondSpring (NASDAQ:BYSI - Get Free Report) last announced its earnings results on Monday, May 12th. The company reported ($0.06) earnings per share (EPS) for the quarter.
BeyondSpring Company Profile
(
Get Free Report)
BeyondSpring Inc, a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-cancer agent, as well as for the prevention of chemotherapy-induced neutropenia.
Featured Articles
Before you consider BeyondSpring, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BeyondSpring wasn't on the list.
While BeyondSpring currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
